Author's Reply to Comments to: Visual and Anatomic Outcomes after Conversion to Aflibercept in Neovascular Age-Related Macular Degeneration: 12-Month Results
Restricted accessResearch articleFirst published online June, 2017
Author's Reply to Comments to: Visual and Anatomic Outcomes after Conversion to Aflibercept in Neovascular Age-Related Macular Degeneration: 12-Month Results
AghdamKAPielenAFrammeCJunkerBVisual and anatomic outcomes after conversion to aflibercept in neovascular age-related macular degeneration: 12-month results.Eur J Ophthalmol201626(5)473–478